What is the recommended treatment for mild to moderate hyponatremia using oral sodium chloride (NaCl)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Mild to Moderate Hyponatremia Using Oral Sodium Chloride

For mild to moderate hyponatremia, oral sodium chloride supplementation should be used alongside water restriction, with dosing based on severity: 936 mg (4 mL of 23.4% solution) for adults aged 9-50 years, while children under 9 and adults over 50 should have physician-determined dosing. 1

Classification and Assessment of Hyponatremia

  • Hyponatremia is classified as mild (130-135 mEq/L), moderate (125-129 mEq/L), or severe (<125 mEq/L) 2
  • Treatment approach should be determined by:
    • Severity of symptoms (mild: nausea, weakness, headache vs. severe: delirium, seizures) 3
    • Volume status (hypovolemic, euvolemic, or hypervolemic) 4
    • Chronicity (acute vs. chronic) 4

Treatment Approach for Mild Hyponatremia (Na 126-135 mEq/L)

  • Mild hyponatremia without symptoms generally requires only monitoring and water restriction 4
  • Ensure adequate solute intake through salt and protein consumption 5
  • Consider initial fluid restriction to 1,000 mL/day with adjustments based on serum sodium response 2

Treatment Approach for Moderate Hyponatremia (Na 120-125 mEq/L)

  • Implement water restriction to 1,000 mL/day and discontinue diuretics 4
  • For oral sodium chloride supplementation:
    • Standard adult dosing (ages 9-50): 4 mL of 23.4% solution (equivalent to 936 mg) 1
    • For children under 9 and adults over 50: Physician should determine appropriate dosing 1
  • Monitor serum sodium levels regularly to avoid overly rapid correction 4

Special Considerations

  • For hypervolemic hyponatremia (common in cirrhosis):

    • Salt restriction may be necessary (no more than 5-6.5g daily) 4
    • Fluid restriction is helpful in preventing further decreases in serum sodium 4
    • Oral NaCl may worsen ascites and edema in cirrhotic patients 4
  • For hypovolemic hyponatremia:

    • Normal saline infusions are preferred over oral sodium chloride 2
    • Correct the underlying cause of volume depletion 4

Rate of Correction and Monitoring

  • When correcting chronic hyponatremia, the goal rate of increase should be 4-6 mEq/L per 24 hours, not exceeding 8 mEq/L per 24-hour period 4
  • More rapid correction risks osmotic demyelination syndrome (ODS), especially in patients with advanced liver disease, alcoholism, malnutrition, or severe hyponatremia 4
  • Regular monitoring of serum sodium levels is essential during treatment 4

Alternative Treatments for Refractory Cases

  • For patients not responding to fluid restriction and oral sodium chloride:
    • Urea may be considered as a second-line therapy for SIADH 5
    • Vaptans (vasopressin receptor antagonists) can be used short-term (≤30 days) in selected patients 4
    • Albumin infusion may improve serum sodium concentration in some cases 4

Cautions and Pitfalls

  • Avoid overly rapid correction of serum sodium, which can lead to osmotic demyelination syndrome 4, 3
  • In patients with cirrhosis, hypertonic sodium chloride (oral or IV) may worsen ascites and edema 4
  • Patients with severe hyponatremia (<120 mEq/L) or neurological symptoms may require more aggressive treatment with hypertonic saline rather than oral supplementation 4
  • Hourly oral NaCl tablets can be an alternative to IV 3% NaCl for selected patients when careful monitoring is available 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.